BNBX · trading date Oct 9, 2026 · previous close $0.16 · source: Alpaca (IEX feed, not consolidated full-market data).
Key Financials
Revenue
—
Net income
-$15.16M
Total assets
$4.44M
Total liabilities
$2.50M
Stockholders' equity
$2.30M
Cash & equivalents
$1.67M
Operating income
-$16.05M
Operating cash flow
-$12.24M
Capital expenditures
$313.1K
Fiscal year 2025, via 10-K filed 2025-12-22.
A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.
Financial Performance
Operating margin
—
Net margin
—
Free cash flow
-$12.56M
Free cash flow margin
—
Liabilities / assets
56.2%
Equity / assets
51.9%
CapEx / revenue
—
Operating cash flow / net income
0.81×
Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.
"Most recent SEC filing" may differ from the filing used for the financial figures above.
Location
Stony Brook, NY
25 HEALTH SCIENCES DRIVE
Data & Methodology
SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:41 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.